97 related articles for article (PubMed ID: 26056794)
1. Response of Relapsed Pancreatoblastoma to a Combination of Vinorelbine and Oral Cyclophosphamide.
Dhamne C; Herzog CE
J Pediatr Hematol Oncol; 2015 Aug; 37(6):e378-80. PubMed ID: 26056794
[TBL] [Abstract][Full Text] [Related]
2. Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
Saloustros E; Kalbakis K; Vardakis N; Kalykaki A; Milaki G; Rovithi M; Agelaki S; Saridaki Z; Georgoulias V; Mavroudis D
J BUON; 2011; 16(2):215-8. PubMed ID: 21766488
[TBL] [Abstract][Full Text] [Related]
3. Management of pancreatoblastoma in children and young adults.
Glick RD; Pashankar FD; Pappo A; Laquaglia MP
J Pediatr Hematol Oncol; 2012 May; 34 Suppl 2():S47-50. PubMed ID: 22525406
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of recurrent metastatic nasopharyngeal carcinoma with oxaliplatin and doxorubicin.
Venkatramani R; Mascarenhas L
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e307-9. PubMed ID: 24276035
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
[TBL] [Abstract][Full Text] [Related]
6. Pancreatoblastoma in a teenage patient.
Bendell JC; Lauwers GY; Willett C; Clark JW; Warshaw AL; Wain JC; Ryan DP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):150-3; discussion 154. PubMed ID: 16728924
[No Abstract] [Full Text] [Related]
7. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
8. Autologous stem cell transplantation as treatment modality in a patient with relapsed pancreatoblastoma.
Hamidieh AA; Jalili M; Khojasteh O; Ghavamzadeh A
Pediatr Blood Cancer; 2010 Sep; 55(3):573-6. PubMed ID: 20658635
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer.
Grossi F; Pennucci MC; Serrano J; Frola C; Mereu C; Scolaro T; Ratto GB; Tixi L; Ardizzoni A
Anticancer Res; 2002; 22(6B):3519-24. PubMed ID: 12552949
[TBL] [Abstract][Full Text] [Related]
10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
11. Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).
Bennouna J; Havel L; Krzakowski M; Kollmeier J; Gervais R; Dansin E; Serke M; Favaretto A; Szczesna A; Cobo M; Ciuffreda L; Jassem J; Nicolini M; Ramlau R; Amoroso D; Melotti B; Almodovar T; Riggi M; Caux NR; Vaissière N; Tan EH
Clin Lung Cancer; 2014 Jul; 15(4):258-65. PubMed ID: 24954228
[TBL] [Abstract][Full Text] [Related]
12. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer.
Viallet J; Ayoub J; Rousseau P; Souhami L; Hohneker J; Shepherd F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):64-71; discussion 71-2. PubMed ID: 7973771
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral topotecan and bevacizumab combination as second-line treatment for relapsed small-cell lung cancer: an open-label multicenter single-arm phase II study.
Spigel DR; Waterhouse DM; Lane S; Legenne P; Bhatt K
Clin Lung Cancer; 2013 Jul; 14(4):356-63. PubMed ID: 23391616
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancer.
Chehal A; Taher A; Khalil M; Shamseddine A
Breast; 2004 Oct; 13(5):421-4. PubMed ID: 15454199
[TBL] [Abstract][Full Text] [Related]
15. Pancreatoblastoma: case report and review of treatment in the literature.
Murakami T; Ueki K; Kawakami H; Gondo T; Kuga T; Esato K; Furukawa S
Med Pediatr Oncol; 1996 Sep; 27(3):193-7. PubMed ID: 8699999
[TBL] [Abstract][Full Text] [Related]
16. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
17. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M
Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.
Kosmidis PA; Syrigos K; Kalofonos HP; Dimopoulos MA; Skarlos D; Pavlidis N; Boukovinas I; Bafaloukos D; Pectasides D; Bacoyiannis C; Fountzilas G
Anticancer Res; 2012 Jan; 32(1):175-81. PubMed ID: 22213304
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic blastomatous tumor in a child responding to therapy used for hepatoblastoma: case report and review of the literature.
Morgan ER; Perryman JH; Reynolds M; Gonzalez-Crussi FJ
Med Pediatr Oncol; 1996 Apr; 26(4):284-92. PubMed ID: 8600344
[TBL] [Abstract][Full Text] [Related]
20. Pancreatoblastoma in childhood: clinical course and therapeutic management of seven patients.
Défachelles AS; Martin De Lassalle E; Boutard P; Nelken B; Schneider P; Patte C
Med Pediatr Oncol; 2001 Jul; 37(1):47-52. PubMed ID: 11466723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
